Inventor
SHALAUROVA IRINA Y
US20 patents
Patents
20 patentsUS6617167B2Sep 9, 2003
Method of determining presence and concentration of lipoprotein X in blood plasma and serum
LIPOSCIENCE INC61 citations95
US9361429B2Jun 7, 2016
Multi-parameter diabetes risk evaluations
LIPOSCIENCE INC17 citations91
US9483612B2Nov 1, 2016
CHD risk stratification evaluations for subjects with high levels of large HDL-P
LIPOSCIENCE INC4 citations84
US9470771B2Oct 18, 2016
NMR measurements of NMR biomarker GlycA
LIPOSCIENCE INC10 citations83
US10388414B2Aug 20, 2019
Multi-parameter diabetes risk evaluations
LIPOSCIENCE INC6 citations82
US9792410B2Oct 17, 2017
Multi-parameter diabetes risk evaluations
LIPOSCIENCE INC10 citations82
US11231429B2Jan 25, 2022
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter
LIPOSCIENCE INC2 citations73
US11156621B2Oct 26, 2021
Multi-parameter metabolic vulnerability index evaluations
LIPOSCIENCE INC2 citations73
US11037683B2Jun 15, 2021
Multiple-marker risk parameters predictive of conversion to diabetes
LIPOSCIENCE INC1 citations73
US10386355B2Aug 20, 2019
CHD risk stratification evaluations for subjects with high levels of large HDL-P
LIPOSCIENCE INC3 citations73
US9952232B2Apr 24, 2018
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter
LIPOSCIENCE INC4 citations73
US9928345B2Mar 27, 2018
Multiple-marker risk parameters predictive of conversion to diabetes
LIPOSCIENCE INC3 citations73
US10852293B2Dec 1, 2020
NMR measurements of NMR biomarker GlycA
LIPOSCIENCE INC2 citations72
US12130295B2Oct 29, 2024
NMR system and methods for multi-parameter metabolic vulnerability index evaluations
LIPOSCIENCE INC0 citations62
US11990243B2May 21, 2024
Multiple-marker risk parameters predictive of conversion to diabetes
LIPOSCIENCE INC0 citations62
US11988679B2May 21, 2024
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter
LIPOSCIENCE INC0 citations62
US11703501B2Jul 18, 2023
CHD risk stratification evaluations for subjects with high levels of large HDL-P
LIPOSCIENCE INC0 citations62
US11692995B2Jul 4, 2023
NMR measurements of NMR biomarker GlycA
LIPOSCIENCE INC0 citations62
US9483611B2Nov 1, 2016
Protective HDL particle number evaluations
LIPOSCIENCE INC2 citations62
US11710568B2Jul 25, 2023
Multi-parameter diabetes risk evaluations
LIPOSCIENCE INC0 citations61